DE60301862D1 - Kombinationsbehandlung bei akutem myokardinfarkt - Google Patents

Kombinationsbehandlung bei akutem myokardinfarkt

Info

Publication number
DE60301862D1
DE60301862D1 DE60301862T DE60301862T DE60301862D1 DE 60301862 D1 DE60301862 D1 DE 60301862D1 DE 60301862 T DE60301862 T DE 60301862T DE 60301862 T DE60301862 T DE 60301862T DE 60301862 D1 DE60301862 D1 DE 60301862D1
Authority
DE
Germany
Prior art keywords
acute
myokardinfarkt
combination treatment
combination
myocardial infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60301862T
Other languages
English (en)
Other versions
DE60301862T2 (de
Inventor
Pentti Poeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Application granted granted Critical
Publication of DE60301862D1 publication Critical patent/DE60301862D1/de
Publication of DE60301862T2 publication Critical patent/DE60301862T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60301862T 2002-02-01 2003-01-31 Kombinationsbehandlung bei akutem myokardinfarkt Expired - Lifetime DE60301862T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20020197A FI20020197A0 (fi) 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon
FI20020197 2002-02-01
PCT/FI2003/000078 WO2003063870A1 (en) 2002-02-01 2003-01-31 A combination treatment for acute myocardial infarction

Publications (2)

Publication Number Publication Date
DE60301862D1 true DE60301862D1 (de) 2006-02-23
DE60301862T2 DE60301862T2 (de) 2006-07-20

Family

ID=8563019

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60301862T Expired - Lifetime DE60301862T2 (de) 2002-02-01 2003-01-31 Kombinationsbehandlung bei akutem myokardinfarkt

Country Status (19)

Country Link
US (1) US20050255096A1 (de)
EP (1) EP1478362B1 (de)
JP (1) JP2005516050A (de)
CN (1) CN1291718C (de)
AT (1) ATE306267T1 (de)
AU (1) AU2003201980B2 (de)
BR (1) BR0307317A (de)
CA (1) CA2474430C (de)
DE (1) DE60301862T2 (de)
DK (1) DK1478362T3 (de)
ES (1) ES2249707T3 (de)
FI (1) FI20020197A0 (de)
HK (1) HK1077215A1 (de)
IL (1) IL163091A (de)
MX (1) MXPA04007345A (de)
NZ (1) NZ534221A (de)
PL (1) PL212241B1 (de)
WO (1) WO2003063870A1 (de)
ZA (1) ZA200406085B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
US20070010518A1 (en) * 2005-02-18 2007-01-11 Matti Kivikko Method for administering levosimendan
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US8324367B2 (en) 2006-11-03 2012-12-04 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
JP2010514778A (ja) * 2006-12-28 2010-05-06 オリオン コーポレーション 非経口投与のためのレボシメンダン製剤
AU2013205148B2 (en) * 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
WO2021126884A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HF-pEF)
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5626601A (en) * 1995-10-27 1997-05-06 Gary Gershony Vascular sealing apparatus and method
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US5463564A (en) * 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties

Also Published As

Publication number Publication date
PL371741A1 (en) 2005-06-27
ZA200406085B (en) 2005-10-06
DE60301862T2 (de) 2006-07-20
ES2249707T3 (es) 2006-04-01
EP1478362B1 (de) 2005-10-12
CN1291718C (zh) 2006-12-27
CA2474430C (en) 2010-09-28
HK1077215A1 (en) 2006-02-10
US20050255096A1 (en) 2005-11-17
BR0307317A (pt) 2005-01-04
PL212241B1 (pl) 2012-08-31
CN1625398A (zh) 2005-06-08
EP1478362A1 (de) 2004-11-24
WO2003063870A1 (en) 2003-08-07
FI20020197A0 (fi) 2002-02-01
JP2005516050A (ja) 2005-06-02
IL163091A (en) 2012-06-28
CA2474430A1 (en) 2003-08-07
MXPA04007345A (es) 2004-11-26
ATE306267T1 (de) 2005-10-15
DK1478362T3 (da) 2005-11-14
NZ534221A (en) 2007-06-29
AU2003201980B2 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
DK1173178T3 (da) Præparat, der omfatter apomorfin og sildenafil, og anvendelse deraf til behandling af erektil dysfunktion
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
NO20032027L (no) Effektive antitumorbehandlinger
AU1085801A (en) Therapeutic use of long-pulse laser photocoagulation in combination with other treatment modalities
PT1408977E (pt) Terapia de combinacao para o tratamento de falha cardiaca
MY136449A (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide for the treatment of cancer
DE60111622D1 (de) Getrennte dosis therapien mit gefässschädigender aktivität
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
DE60235965D1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
CO5170404A1 (es) Terapia para melanomas
NO20043774L (no) The use of devazenide as analgesic agent
RU2002118801A (ru) Способ профилактики катетер-ассоциированных инфекций

Legal Events

Date Code Title Description
8364 No opposition during term of opposition